Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Line Tegtmeier Frandsen"'
Autor:
Jacob Holmen Terkelsen, Martin Hollænder, Kasper Bredal, Sara Munk Nielsen, Kristoffer Vittrup Koed Thomsen, Amanda Baggerman, Emilia Ofverlind, Alptug Mertcan Koc, Hannah Pakes, Marco Bassam Mahdi, Sanne Ørnfeldt Larsen, Vanessa Parra Gonzalez, Johannes Riis, Line Tegtmeier Frandsen, Dorte Melgaard, Anne Lund Krarup
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Food bolus obstruction (FBO) leading to hospital treatment is often associated with eosinophilic oesophagitis (EoE), stenosis, or oesophageal cancer (1). Danish national guidelines recommend that patients with FBO undergo a diagno
Externí odkaz:
https://doaj.org/article/39a7e480124f458586b490b47a8a5bfb
Autor:
Kasper Bredal, Line Tegtmeier Frandsen, Jacob Holmen Terkelsen, Martin Hollænder Nielsen, Dorte Melgaard, Anne Lund Krarup
Publikováno v:
BMC Pediatrics, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Background A low incidence of eosinophilic esophagitis (EoE) in children in the North Denmark Region (NDR) were measured in 2007–2017. Few of the children diagnosed before 2017 were treated to remission suggesting a lack of awareness. Whil
Externí odkaz:
https://doaj.org/article/fddfa4347a18446d9bc366a340a6ac2d
Publikováno v:
United European Gastroenterology Journal
Frandsen, L T, Westmark, S, Melgaard, D & Krarup, A L 2021, ' Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis—Results from the population-based DanEoE cohort shows a low complication rate ', United European Gastroenterology Journal, vol. 9, no. 8, pp. 910-918 . https://doi.org/10.1002/ueg2.12146
Frandsen, L T, Westmark, S, Melgaard, D & Krarup, A L 2021, ' Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis—Results from the population-based DanEoE cohort shows a low complication rate ', United European Gastroenterology Journal, vol. 9, no. 8, pp. 910-918 . https://doi.org/10.1002/ueg2.12146
BackgroundProton pump inhibitors (PPIs) are often the first drug of choice in the treatment of eosinophilic oesophagitis (EoE), and in Denmark 8 weeks of high-dose PPI therapy is recommended as first-line treatment followed by rebiopsying, reflecting